| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000022089 |
| Receipt No. | R000025470 |
| Official scientific title of the study | Study of the usefulness of non invasive liver function evaluation technology by ultrasound elastography |
| Date of disclosure of the study information | 2016/04/27 |
| Last modified on | 2016/04/27 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Study of the usefulness of non invasive liver function evaluation technology by ultrasound elastography | |
| Title of the study (Brief title) | Study of the usefulness of non invasive liver function evaluation technology by ultrasound elastography | |
| Region |
|
|
| Condition | |||
| Condition | Not limited | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To develop an algorithm for estimate fibrosis, inflammation and steatosis of the liver using Real-time Tissue Elastography (below RTE), Shear Wave Measurement (below SWM), and attenuation measurement, for liver disease patients undergoing liver biopsy or liver resection. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To develop an algorithm for estimate fibrosis, inflammation and steatosis of the liver |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | no gender restriction
20 years old more |
|||
| Key exclusion criteria | Patients can not be measured by removing the ROI (region of interest Region of Interest) of elastography from tumor
Pregnant women or the patient during breast-feeding. |
|||
| Target sample size | 450 | |||
| Research contact person | |
| Name of lead principal investigator | Masatoshi Kudo |
| Organization | Kinki university faculty of medicine |
| Division name | Department of gastroenterology and gepatology |
| Address | 377-2, Ohnodai, Osaka-sayama, Osaka, Japan |
| TEL | 072-366-0221 |
| yada@med.kindai.ac.jp | |
| Public contact | |
| Name of contact person | Norihisa Yada |
| Organization | Kinki university faculty of medicine |
| Division name | Department of gastroenterology and hepatology |
| Address | 377-2, Ohnodai, Osaka-sayama, Osaka, Japan |
| TEL | 073-366-0221 |
| Homepage URL | |
| yada@med.kindai.ac.jp | |
| Sponsor | |
| Institute | Kinki university faculty of medicine, Department of gastroenterology and hepatology |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Ehime university
Musashino red cross hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | no |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025470 |